[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643528":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":29,"collaborators":11,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":11,"eligibilityCriteria":38,"healthyVolunteers":35,"sex":39,"minAge":40,"maxAge":11,"enrollmentInfo":41,"targetDuration":11,"studyType":44,"phases":45,"briefSummary":47,"conditions":48,"keywords":11,"overallStatus":50,"whyStopped":11,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":11},{"fullName":5,"class":6},"Beni-Suef University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"control group","ACTIVE_COMPARATOR",null,[13],"Drug: Standard medical treatment",{"label":15,"type":10,"description":16,"interventionNames":17},"test group","l carnitine",[18,13],"Drug: L Carnitine",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","L Carnitine","L-Carnitine, a natural substance present in the body, is essential for energy metabolism in mammals. l-carnitine presents as a drug.",[15],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"Standard medical treatment","Standard medical treatment for hepatic patient admitted to icu",[9,15],{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Ayten Amr Abd El-monem","Principal Investigator","100643528","phase-4-evaluation-of-the-clinical-impact-of-adjunctive-l-carnitine-therapy-in-critically-ill-hepatic-patients-admitted-to-intensive-care-unit-100643528",false,"NCT07642076","Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit","Inclusion Criteria:\n\n* Age more than 18 years old\n* male or female with confirmed liver disease admitted to intensive care unit, including:\n* Acute-on-chronic liver failure (ACLF)\n* Hepatic encephalopathy\n* spontaneous bacterial peritonitis (SBP)\n* variceal bleeding\n* fulminant hepatitis\n* Hepatorenal syndrome\n* Ascites\n* Etc\n\nExclusion Criteria:\n\n* Age of less than 18 years old\n* Pregnancy or Lactation\n* patients have seizure\n* patient on warfarin","ALL","18 Years",{"count":42,"type":43},58,"ESTIMATED","INTERVENTIONAL",[46],"PHASE4","This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.",[49],"Hepatic","NOT_YET_RECRUITING","2026-06-07",{"date":53,"type":54},"2026-06-11","ACTUAL",{"date":56,"type":43},"2026-06",{"date":58,"type":43},"2027-03",{"name":5,"class":6}]